LA Private

October 2024

Arovella receives R&D tax incentive and new advisory board

Arovella Therapeutics (ASX:ALA) has recently released its quarterly report, announcing the receipt of a $3.0 million Research and Development (R&D) Tax Incentive refund, with an additional $0.3 million expected shortly. This funding enhances Arovella’s financial position as it advances its lead asset, ALA-101, towards first-in-human clinical trials. CEO Dr Michael Baker stated, “The R&D Tax […]

Arovella receives R&D tax incentive and new advisory board Read More »

Beach Energy achieves first gas production from Thylacine West

Beach Energy (ASX:BPT) has successfully commenced gas production from its Thylacine West 1 and 2 development wells, which are now connected to the Otway Gas Plant. This milestone was achieved on 25 October 2024 and signifies a major advancement in the offshore drilling and development program within the Otway Basin. The Thylacine West development wells

Beach Energy achieves first gas production from Thylacine West Read More »

Whitehaven’s Queensland mines shine amid Q1 FY25 results

Whitehaven Coal (ASX:WHC) has reported a robust start to FY25, driven by gains in its Queensland operations. The company’s September quarter saw a managed run-of-mine (ROM) production of 9.7 million tonnes (Mt), consistent with the previous June quarter. Queensland operations contributed significantly, with ROM production up 11% from June, reaching 5.3Mt. This improvement was attributed

Whitehaven’s Queensland mines shine amid Q1 FY25 results Read More »

ResMed posts double-digit revenue growth driven by sleep device sales

ResMed (ASX:RMD), a global leader in sleep and respiratory care, reported strong results for the first quarter of FY25, with revenue climbing 11% year-over-year to $1.2bn. This growth was driven by robust sales of sleep apnoea devices and a growing presence in the digital health sector. Gross margins improved to 58.6%, as operational efficiencies and

ResMed posts double-digit revenue growth driven by sleep device sales Read More »

Helloworld reports soaring total transaction value

Helloworld Travel (ASX:HLO) has posted strong FY24 financial results, reflecting the ongoing rebound in the travel sector and strategic acquisitions. The company, a prominent travel distribution network operating across Australia, New Zealand, and the South Pacific, saw its Total Transaction Value (TTV) soar to $4.2bn — a 62.5% increase from the previous year. Helloworld operates

Helloworld reports soaring total transaction value Read More »

Unibail-Rodamco-Westfield sees strong Q3 as it sharpens focus on European assets

Unibail-Rodamco-Westfield (ASX:URW), a leading owner and operator of shopping centres and commercial properties, reported a solid performance for Q3 2024, driven by robust retail sales and increased foot traffic at its key sites. The company recorded a 9.1% increase in turnover compared to the same period last year, with the Convention & Exhibition segment showing

Unibail-Rodamco-Westfield sees strong Q3 as it sharpens focus on European assets Read More »

Orthocell secures $17m to fund US entry

Orthocell (ASX:OCC) has secured $17m in a recent capital raising initiative, aimed at funding the US launch of its flagship Remplir device. The funds will also support expansion into Singapore, Southeast Asia, and Europe, and be allocated to scaling up manufacturing infrastructure and enhancing cost efficiency through automation projects. The Remplir device is designed to facilitate

Orthocell secures $17m to fund US entry Read More »

Nasdaq hits all-time high

On Friday, the Nasdaq Composite surged to an all-time high, ending a turbulent week with a strong rally led by tech giants. The Nasdaq rose 1.3%, outperforming other indices, while the S&P 500 gained 0.6%, both reaching new peaks. In contrast, the Dow Jones Industrial Average saw only a modest increase of 0.1%, adding 38

Nasdaq hits all-time high Read More »